ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 526417 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 526417; 2) Community: the network communities that were significantly associated with the response to NSC 526417; 3) Molecule: the relationships between components within communities and NSC 526417; 4) MDR: the compounds that were significantly associated with the NSC 526417.

NSC Compound Enrichment Correlation
NSC 744025 diethyl 2-[4-(5-[(11aS)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxypentyl)piperazino]ethylphosphonate 0.0385067071027345 0.64224174
NSC 759216 (3-(4-bromophenyl)-5-(1,3-diphenyl-1H-pyrazol-4-yl)-4,5-dihydropyrazol-1-yl)(4-methoxyphenyl)methanone 0.0385067071027345 0.14219559
NSC 763646 (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole 0.0385067071027345 0.028710029
NSC 79563 1,3-bis(4-chlorobenzyl)-2-(phenanthren-9-yl)hexahydropyrimidine 0.0385067071027345 0.31767447
NSC 99733 Rheumygin 0.0385067071027345 0.17417328
NSC 103704 Null 0.0385203205529756 0.14058313
NSC 105023 RUBIFLAVIN 0.0385203205529756 0.26138199
NSC 110383 Naphtho[1,2-c]quinolizinium, 13-methyl-, chloride 0.0385203205529756 0.46200421
NSC 111135 Null 0.0385203205529756 0.11282427
NSC 23936 Null 0.0385203205529756 -0.0033980422
Total:86  Current:67    [First] [Prev] [Next] [Last]